First International Bank & Trust Pfizer Inc Transaction History

First International Bank & Trust

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 12, 2023	SELL	$32.09 - $37.51 $19,254 - $22,506	-600 Reduced 8.22%	6,700 $222,000
Q4 2022 Feb 09, 2023	BUY	$41.75 - $54.5 $12,525 - $16,350	300 Added 4.29%	7,300 $374,000
Q2 2022 Aug 09, 2022	SELL	$46.53 - $55.17 $2,233 - $2,648	-48 Reduced 0.68%	7,000 $367,000
Q1 2022 Apr 08, 2022	BUY	$45.75 - $56.69 $2,196 - $2,721	48 Added 0.69%	7,048 $365,000
Q4 2021 Mar 29, 2022	BUY	$41.32 - $61.25 $289,240 - $428,750	7,000 New	7,000 $413,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of First International Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on First International Bank & Trust with notifications on news.